Upregulation of phospholipase D expression and activation in ventricular pressure-overload hypertrophy

Journal of Pharmacological Sciences

Volumn 98, Issue 3, 2005, Pages 244-254

  Peivandi, Ali A ^a   Huhn, Alexander ^a   Lehr, Hans Anton ^a   Jin, Shenchu ^a   Troost, Joachim ^a   Salha, Sonia ^a   Weismüller, Tobias ^a   Löffelholz, Konrad ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Cardiac hypertrophy; Phospholipase D; Protein kinase C; Signal transduction; adrenoceptor

Indexed keywords

4BETA PHORBOL DIBUTYRATE; ALPHA ADRENERGIC RECEPTOR; CAVEOLIN 3; MESSENGER RNA; PHENYLEPHRINE; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; PROTEIN KINASE C;

ABDOMINAL AORTA; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; AORTA SURGERY; ARTICLE; CAVEOLA; CELL FRACTIONATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION REGULATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 24744461909     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FPE04008X     Document Type: Article

References (54)

1. Sugden PH, Clerk A. Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am J Cardiol. 1999;83:64H-69H.
2. Exton JH. Phospholipase D - Structure, regulation and function. Rev Physiol Biochem Pharmacol. 2002;144:1-94.
3. Hale CC, Ebeling EG, Hsu FF, Ford DA. The selective activation of the cardiac sarcolemmal sodium-calcium exchanger by plasmalogenic phosphatidic acid produced by phospholipase D. FEBS Lett. 1998;422:247-251.
4. 2+ and cardiac force. Am J Physiol. 1996;271:H651-H659.
5. Rizzo MA, Shome K, Vasudevan C, Stolz DB, Sung TC, Frohman MA, et al. Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent Raf-1 translocation to the plasma membrane and the activation of the mitogenactivated protein kinase pathway. J Biol Chem. 1999;274:1131-1139.
6. Rizzo MA, Shome K, Watkins SC, Romero G. The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras. J Biol Chem. 1999;275:23911-23918.
7. Clerk A, Sugden PH. Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res. 2000;86:1019-1023.
8. Lindmar R, Löffelholz K. Phospholipase D in rat myocardium: formation of lipid messengers and synergistic activation by Gprotein and protein kinase C. Biochem Pharmacol. 1998;56:799-805.
9. Cockcroft S. Signalling roles of mammalian phospholipase D1 and D2. Cell Mol Life Sci. 2001;58:1674-1687.
10. Liscovitch M, Czarny M, Fiucci G, Tang X. Phospholipase D: molecular and cell biology of a novel gene familiy. Biochem J. 2000;345:401-415.
11. Dhalla NS, Xu YJ, Sheu SS, Tappia PS, Panagia V. Phosphatidic acid: a potential signal transducer for cardiac hypertrophy. J Mol Cell Cardiol. 1997;29:2865-2871.
12. Eskildsen-Helmond YEG, Van Heugten HAA, Lamers JMJ. Regulation and functional significance of phospholipase D in myocardium. Mol Cell Biochem. 1996;157:39-48.
13. Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. New Engl J Med. 1999;341:1276-1283.
14. Akhter SA, Luttrell LM, Rockman HA, Iaccarino G, Lefkowitz RJ, Koch WJ. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 1998;280:574-577.
15. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiological response. FASEB J. 1991;5:3037-3046.
16. Sugden PH, Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med. 1998;76:725-746.
17. Steinberg S. Many pathways to cardiac hypertrophy. J Mol Cell Cardiol. 2000;32:1381-1384.
18. Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res. 1998;39:89-105.
19. Dorn GW, Robbins J, Sugden PH. Phenotyping hypertrophy. Eschew Obfuscation. Circ Res. 2003;92:1171-1175.
20. Lehr HA, Hansen DA, Kussick S, Li M, Hwang H, Krummenauer F, et al. Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol. 1999;30:1314-1320.
21. Morris AJ, Frohman MA, Engebrecht J. Measurement of phospholipase D activity. Analytical Biochem. 1997;252:1-9.
22. Martin TW, Michaelis K. P2-Purinergic agonists stimulate phosphodiesteratic cleavage of phosphatidylcholine in endothelial cells. J Biol Chem. 1989;264:8847-8856.
23. Weismüller T, Klein J, Löffelholz K. Effects of norepinephrine and cardiotrophin-1 on phospholipase D activity and incorporation of myristic acid into phosphatidiylcholine in rat heart. J Pharmacol Sci. 2004;95:335-340.
24. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
25. Ehrlich HA. PCR technology: principles and applications of DNA amplification. New York: Stockton Press; 1989.
26. Kedzierski W, Porter JC. A novel non-enzymatic procedure for removing DNA template from RNA transcription mixtures. Biotechniques. 1991;10:210-214.
27. Park JB, Kim JH, Kim Y, Ha SH, Kim JH, Yoo JS, et al. Cardiac phospholipase D2 localizes to sarcolemmal membranes and is inhibited by α-actinin in an ADP-ribosylation factor-reversible manner. J Biol Chem. 2000;275:21295-21301.
28. Jin S, Schatter B, Weichel O, Walev I, Ryu SH, Klein J. Stability of phospholipase D in primary astrocytes. Biochem Biophys Res Commun. 2002;297:545-551.
29. Brühl A, Faldum H, Löffelholz K. On the degradation of phosphatidylethanol in heart and other organs. Biochim Biophys Acta. 2003;1633:84-89.
30. 1-adrenoceptors mediate positive inotropic effect and changes in phosphatidylinositol metabolism. Circ Res. 1991;68:1179-1190.
31. Kötter K, Jin S, von Eichel-Streiber C, Park JB, Ryu SH, Klein J. Activation of astroglial phospholipase D activity by phorbol ester involves ARF and Rho proteins. Biochem Biophys Acta. 2000;1485:153-162.
32. Braun MU, LaRosée P, Schön S, Borst MM, Strasser RH. Differential regulation of cardiac protein kinase C isozyme expression after aortic banding in rat. Cardiovasc Res. 2002;56:52-63.
33. Kurz T, Kemken D, Mier K, Weber I, Richardt G. Human cardiac phospholipase D is tightly controlled by phosphatidylinositol 4,5-bisphosphate. J Mol Cell Cardiol. 2004;36:225-232.
34. Dent MR, Singal T, Dhalla NS, Tappia PS. Expression of phospholipase D isozymes in scar and viable tissue in congestive heart failure due to myocardial infarction. J Cell Mol Med. 2004;8:526-536.
35. Xu YJ, Yau L, Yu LP, Elimban V, Zahradka P, Dhalla NS. Stimulation of protein synthesis by phosphatidic acid in rat cardiomyocytes. Biochem Pharmacol. 1996;52:1735-1740.
36. 2+ signaling pathways. Curr Biol. 1998;8:386-392.
37. Dunnmon PM, Iwaki K, Henderson SA, Sen A, Chien KR. Phorbol esters induce immediate-early genes and activate cardiac gene transcription in neonatal rat myocardial cells. J Mol Cell Cardiol. 1990;20:901-910.
38. Peivandi A, Troost J, Vahl C, Löffelholz K. Upregulation of α-adrenoceptor-mediated phospholipase C activity in rat ventricular pressure-overload hypertrophy. Thorac Cardiovasc Surg. 2005;53 Suppl 1:V30.
39. Clerk A, Sugden PH. Regulation of phospholipases C and D in rat ventricular myocytes: stimulation by endothelin-1, bradykinin and phenylephrine. J Mol Cell Cardiol. 1997;29:1593-1604.
40. O'Connell TD, Ishizaka S, Nakamura A, Swigart PM, Rodrigo MC, Simpson GL, et al. The α1A/C- and α1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest. 2003;111:1783-1791.
41. Rapacciuolo A, Esposito G, Caron K, Mao L, Thomas SA, Rockman HA. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J Am Coll Cardiol. 2001;38:876-882.
42. 1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. J Biol Chem. 1996;271:5839-5843.
43. 1- adrenoceptor subtype- and protein kinase C isoform-dependence of norepinephrine's actions in cardiomyocytes. J Mol Cell Cardiol. 2000;32:1193-1209.
44. Thorburn A. Ras activity is required for phenylephrine-induced activation of mitogen-activated protein kinase in cardiac muscle cells. Biochem Biophys Res Commun. 1994;205:1417-1422.
45. 1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem. 1997;272:14057-14061.
46. Hong JH, Oh SO, Lee M, Kim YR, Kim DU, Hur GM, et al. Enhancement of lysophosphatidic acid-induced ERK phosphorylation by phospholipase D1 via the formation of phosphatidic acid. Biochem Biophys Res Commun. 2001;281:1337-1342.
47. Frey N, Olson EN. Modulating cardiac hypertrophy by manipulating myocardial lipid metabolism? Circulation. 2002;105:1152-1154.
48. Stewart AF, Rokosh DG, Bailey BA, Karns LR, Chang KC, Long CS, et al. Cloning of the rat α1C-adrenergic receptor from cardiac myocytes. α1C, α1B and α1D mRNAs are present in cardiac myocytes but not in cardiac fibroblasts. Circ Res. 1994;75:796-802.
49. Fiucci G, Czarny M, Lavie Y, Zhao D, Berse B, Blusztajn JK, et al. Changes in phospholipase D isoform activity and expression in multidrug-resistant human cancer cells. Int J Cancer. 2000;85:882-888.
50. Kim JH, Han JM, Lee S, Kim Y, Lee TG, Park JB, et al. Phospholipase D1 in caveolae: regulation by protein kinase Cα and caveolin-1. Biochemistry. 1999;38:3763-3769.
51. Xu L, Shen Y, Troy J, Bryant A, Luo J, Frankel P, et al. Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains. Biochem Biophys Res Commun. 2000;273:77-83.
52. Simons K, Ikonen E. Functional rafts in cell membranes. Nature. 1997;387:569-572.
53. Iyer SS, Kusner DJ. Association of phospholipase D activity with the detergent-insoluble cytoskeleton of U937 promonocytic leukocytes. J Biol Chem. 1999;274:2350-2359.
54. Meacci E, Donati C, Cencetti F, Romiti E, Farnararo M, Bruni P. Receptor-activated phospholipase D is present in caveolin-3-enriched light membranes of C2C12 myotubes. FEBS Lett. 2000;473:10-14.